We found that TXNIP RNA levels were six times lower in melanoma as in healthy control samples (Fig. 2A), and also significantly downregulated in malignant (PM or MM) versus benign (BMN) lesions in the two microarray datasets analyzed (Fig. 2B,C; Supp. This evidence concerns the gene TXNIP and Miyoshi myopathy.